Friendly Links


PubMed
Or try searching using predefined terms:
Follow me on Twitter
Infection with Helicobacter pylori increases insulin resistance
By Helen Albert
29 December 2010
Diabetologia 2010; Advance online publication

MedWire News: Study results show that Helicobacter pylori infection increases insulin resistance through elevation of fetuin A, which could indicate a link with diabetes.

"Among the various factors capable of inducing insulin resistance, the upregulation of α2-Heremans Schmid glycoprotein, also known as human fetuin A, has been linked with impaired insulin sensitivity, glucose metabolism and, subsequently, the onset of diabetes mellitus," explain Spyros Potamianos (University of Thessaly, Larissa, Greece) and colleagues.

Certain pathogens have been observed to increase levels of fetuin A. To investigate whether H. pylori is such an infection, the researchers measured levels of fetuin A and fasting insulin and glucose in 105 non-diabetic individuals who were undergoing esophagogastroduodenoscopy due to dyspeptic complaints.

As reported in the journal Diabetologia, 72 participants were found to be infected with H. pylori and 33 were not. In multivariate analysis (adjusted for age, gender, body mass index, lipids, and C-reactive protein), H. pylori-positive individuals had significantly higher levels of fetuin A (0.74 vs 0.57 g/l) and homeostasis model assessment of insulin resistance (2.6-2.8 vs 1.9-2.0) than those who were not infected.

Potamianos and team say that the "data from the present study are consistent with the notion that H. pylori infection may induce insulin resistance."

However, they caution that "the present model cannot be regarded as final, since it was shaped based upon the findings of a study of a more or less observational nature."

They conclude: "Further research is therefore required, preferably using a more 'mechanistic' approach so that the conclusions presented above may be verified, and perhaps expanded by the inclusion of other constituents, eg, adipokines, gastrin or somatostatin, before a widely accepted mechanism is completely established."

MedWire (www.medwire-news.md) is an independent clinical news service provided by Current Medicine Group, a trading division of Springer Healthcare Limited. © Springer Healthcare Ltd; 2010

Free abstract

Comments
This article currently has no comments
Post a Comment

Please note, email address is required but not shown. Comments are moderated and will not appear until they have been approved. Please see the disclaimer for more information